Methamphetamine administration modifies leukocyte proliferation and cytokine production in murine tissues

Immunobiology

Volumn 218, Issue 8, 2013, Pages 1063-1068

  Peerzada, Habibullah ^a   Gandhi, Jay A ^a   Guimaraes, Allan J ^b   Nosanchuk, Joshua D ^c   Martinez, Luis R ^a,c  

^a LONG ISLAND UNIVERSITY   (United States)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokines; Leukocytes; Methamphetamine

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; METHAMPHETAMINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; KIDNEY; LEUKOCYTE; LIVER; LUNG; MACROPHAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; BRAIN; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; IMMUNITY; INFLAMMATION; KIDNEY; LEUKOCYTES; LIVER; METHAMPHETAMINE; MICE; MICE, INBRED C57BL;

EID: 84878615644     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.02.001     Document Type: Article

References (20)

1. Cho A.K., Melega W.P., et al. Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 2001, 39(2):161-166.
2. Freire-Garabal M., Balboa J.L., et al. Effects of amphetamine on T-cell immune response in mice. Life Sci. 1991, 49(16):PL107-PL112.
3. Gonzales R., Mooney L., et al. The methamphetamine problem in the United States. Annu. Rev. Public Health 2010, 31:385-398.
4. Harris D.S., Boxenbaum H., et al. The bioavailability of intranasal and smoked methamphetamine. Clin. Pharmacol. Ther. 2003, 74(5):475-486.
5. Iwasa M., Maeno Y., et al. Induction of apoptotic cell death in rat thymus and spleen after a bolus injection of methamphetamine. Int. J. Legal Med. 1996, 109(1):23-28.
6. Karch S.B., Stephens B.G. Toxicology and pathology of deaths related to methadone: retrospective review. West. J. Med. 2000, 172(1):11-14.
7. Logan B.K., Fligner C.L., et al. Cause and manner of death in fatalities involving methamphetamine. J. Forensic Sci. 1998, 43(1):28-34.
8. Mankatittham W., Likanonsakul S., et al. Characteristics of HIV-infected tuberculosis patients in Thailand. Southeast Asian J. Trop. Med. Public Health 2009, 40(1):93-103.
9. Martinez L.R., Mihu M.R., et al. Methamphetamine enhances histoplasmosis by immunosuppression of the host. J. Infect. Dis. 2009, 200(1):131-141.
10. Melega W.P., Cho A.K., et al. Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. Synapse 2007, 61(4):216-220.
11. Pevzner E.S., Robison S., et al. Tuberculosis transmission and use of methamphetamines in Snohomish County, WA, 1991-2006. Am. J. Public Health 2010, 100(12):2481-2486.
12. Potula R., Hawkins B.J., et al. Methamphetamine causes mitrochondrial oxidative damage in human T lymphocytes leading to functional impairment. J. Immunol. 2010, 185(5):2867-2876.
13. Saito M., Terada M., et al. Effects of single or repeated administrations of methamphetamine on immune response in mice. Exp. Anim. 2008, 57(1):35-43.
14. Simon S.L., Richardson K., et al. A comparison of patterns of methamphetamine and cocaine use. J. Addict. Dis. 2002, 21(1):35-44.
15. Talloczy Z., Martinez J., et al. Methamphetamine inhibits antigen processing, presentation, and phagocytosis. PLoS Pathog. 2008, 4(2):e28.
16. Verachai V., Phutiprawan T., et al. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand. Southeast Asian J. Trop. Med. Public Health 2002, 33(4):849-851.
17. Volkow N.D., Fowler J.S., et al. Distribution and pharmacokinetics of methamphetamine in the human body: clinical implications. PLoS one 2010, 5(12):e15269.
18. Wells S.M., Buford M.C., et al. Acute inhalation exposure to vaporized methamphetamine causes lung injury in mice. Inhal. Toxicol. 2008, 20(9):829-838.
19. Wilson J.M., Kalasinsky K.S., et al. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat. Med. 1996, 2(6):699-703.
20. Ye L., Peng J.S., et al. Methamphetamine enhances Hepatitis C virus replication in human hepatocytes. J. Viral Hepat. 2008, 15(4):261-270.